EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Dissecting Tumor Heterogeneity by Liquid Biopsy—A Comparative Analysis of Post-Mortem Tissue and Pre-Mortem Liquid Biopsies in Solid Neoplasias

Tatiana Mögele, Kathrin Hildebrand, Aziz Sultan, Sebastian Sommer, Lukas Rentschler, Maria Kling, Irmengard Sax, Matthias Schlesner iD, Bruno Märkl, Martin Trepel, Maximilian Schmutz iD, Rainer Claus iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157614 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tatiana Mögele und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany. Hauptthemen laut MEDLINE: Neoplasms, Genetic Heterogeneity, Circulating Tumor DNA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural funding program of the Faculty of Medicine, University of Augsburg (ALPS)., Intramural funding program (ALPS trial) of the Faculty of Medicine, University of Augsburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor heterogeneity encompasses genetic, epigenetic, and phenotypic diversity, impacting treatment response and resistance. Spatial heterogeneity occurs both inter- and intra-lesionally, while temporal heterogeneity results from clonal evolution. High-throughput technologies like next-generation sequencing (NGS) enhance tumor characterization, but conventional biopsies still do not adequately capture genetic heterogeneity. Liquid biopsy (LBx), analyzing circulating tumor DNA (ctDNA), provides a minimally invasive alternative, offering real-time tumor evolution insights and identifying resistance mutations overlooked by tissue biopsies. This study evaluates the capability of LBx to capture tumor heterogeneity by comparing genetic profiles from multiple metastatic lesions and LBx samples. Eight patients from the Augsburger Longitudinal Plasma Study with various types of cancer provided 56 postmortem tissue samples, which were compared against pre-mortem LBx-derived circulating-free DNA sequenced by NGS. Tissue analyses revealed significant mutational diversity (4–12 mutations per patient, VAFs: 1.5–71.4%), with distinct intra- and inter-lesional heterogeneity. LBx identified 51 variants (4–17 per patient, VAFs: 0.2–31.1%), which overlapped with mutations from the tissue samples by 33–92%. Notably, 22 tissue variants were absent in LBx, whereas 18 LBx-exclusive variants were detected (VAFs: 0.2–2.8%). LBx effectively captures tumor heterogeneity, but should be used in conjunction with tissue biopsies for comprehensive genetic profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGenetic HeterogeneityCirculating Tumor DNAHumansLiquid BiopsyHigh-Throughput Nucleotide SequencingMutationMaleFemaleAutopsyMiddle AgedAgedBiomarkers, Tumor

Stichwörter der Autor:innen

NGSclonal evolutionliquid biopsymutational landscape and molecular pathologytumor heterogeneity

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Pathology, Faculty of Medicine, University of Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany.
  • Bavarian Cancer Research Center (BZKF), 91054 Erlangen, Germany.
  • Hematology and Oncology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
  • MVZ-Onkologie im Elisenhof, 80335 Munich, Germany.
  • Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, 86159 Augsburg, Germany.
  • Comprehensive Cancer Center Augsburg (CCCA), 86156 Augsburg, Germany.

ORCID-Profile: Matthias Schlesner, Maximilian Schmutz, Rainer Claus

Förderung

  • Intramural funding program of the Faculty of Medicine, University of Augsburg (ALPS).
  • Intramural funding program (ALPS trial) of the Faculty of Medicine, University of Augsburg

Zitieren

APA

Mögele, T., Hildebrand, K., Sultan, A., Sommer, S., Rentschler, L., Kling, M., Sax, I., Schlesner, M., Märkl, B., Trepel, M., Schmutz, M., & Claus, R. (2025). Dissecting Tumor Heterogeneity by Liquid Biopsy—A Comparative Analysis of Post-Mortem Tissue and Pre-Mortem Liquid Biopsies in Solid Neoplasias. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157614

Vancouver

Mögele T, Hildebrand K, Sultan A, Sommer S, Rentschler L, Kling M, et al. Dissecting Tumor Heterogeneity by Liquid Biopsy—A Comparative Analysis of Post-Mortem Tissue and Pre-Mortem Liquid Biopsies in Solid Neoplasias. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157614

BibTeX
@article{Mgele2025,
  author = {Mögele, Tatiana and Hildebrand, Kathrin and Sultan, Aziz and Sommer, Sebastian and Rentschler, Lukas and Kling, Maria and Sax, Irmengard and Schlesner, Matthias and Märkl, Bruno and Trepel, Martin and Schmutz, Maximilian and Claus, Rainer},
  title = {Dissecting Tumor Heterogeneity by Liquid Biopsy—A Comparative Analysis of Post-Mortem Tissue and Pre-Mortem Liquid Biopsies in Solid Neoplasias},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157614}
}
Kostenlos starten →